These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 347631)

  • 1. Appearance and evolution of anti-Da (B cell-specific) antibodies after planned immunizations.
    Belvedere M; Richiardi P; Savi M; Curtoni ES; Carbonara AO; Ceppellini R
    Tissue Antigens; 1978 Feb; 11(2):153-62. PubMed ID: 347631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sera from volunteers immunized by planned blood transfusions as source of DR cytotoxic typing reagents.
    Belvedere M; Richiardi P; Curtoni ES; Pellegrino MA; Ferrone S
    Immunol Commun; 1979; 8(1):93-106. PubMed ID: 311335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA antibodies cytotoxic only for B lymphocytes.
    Richiardi P; Diotallevi P; Matejc T; Carbonara AO; Curtoni ES
    Tissue Antigens; 1977 Oct; 10(4):323-9. PubMed ID: 72430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Planned immunization of human volunteers with HLA-DR incompatible lymphocytes I. Serological aspects.
    Madsen M; Johnsen HE; Kristensen T; Jørgensen F; Lamm LU; Kissmeyer-Nielsen F
    Tissue Antigens; 1982 Jul; 20(1):33-46. PubMed ID: 6957026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell antigens of the HLA system: a simple serotyping technique based on non-cytotoxic anti-beta2-microglobulin reagents.
    Bernoco D; Bernoco M; Ceppellini R; Poulik MD; Leeuwen A; Rood JJ
    Tissue Antigens; 1976 Oct; 8(4):253-60. PubMed ID: 62417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-specific transfusions. Donor-recipient HLA compatibility, recipient HLA haplotype, and antibody production.
    Radvany RM; Patel KM
    Transfusion; 1988; 28(2):137-41. PubMed ID: 3281335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and use of high titered anti-HLA-DR sera in PHA-blast complement fixation and B-lymphocytotoxicity techniques.
    Lepage V; Gaudy Y; Terrier E; Dausset J; Colombani J
    Tissue Antigens; 1981 Jan; 17(1):37-42. PubMed ID: 6166083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA, DRW (IA-like) and additional surface antigens expressed on adenoid T and B lymphocytes.
    Gazit E; Mizrahi Y; Orgad S; Efter T; Lewenstein M; Ostfeld E
    Vox Sang; 1979; 37(4):193-200. PubMed ID: 386611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary serological analysis for identification of direct monoclonal antibodies against surface structures of HLA typed human lymphocytes].
    Richiardi P; Crepaldi T; Amoroso A
    G Batteriol Virol Immunol; 1980; 73(7-12):165-79. PubMed ID: 7030845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New human MHC class I antigens segregating with HLA-A antigens detected on some lymphocyte subpopulations.
    Mitsuishi Y; Falkenrodt A; Urlacher A; Tongio MM; Mayer S
    Hum Immunol; 1986 Feb; 15(2):175-97. PubMed ID: 3485086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-HLA antibodies in nephropathic patients].
    Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
    G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome.
    Christiaans MH; van Hooff JP; Nieman F; van den Berg-Loonen EM
    Transplantation; 1999 Apr; 67(7):1029-35. PubMed ID: 10221489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of antiidiotypic antibodies to donor HLA-A2 following blood transfusions in a highly sensitized HLA-A2+ recipient.
    Burlingham WJ; Pan MH; Mason B; Ceman S; Sollinger HW
    Transplantation; 1988 Jun; 45(6):1066-71. PubMed ID: 3289148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superiority of AbCross enzyme-linked immunosorbent assay cross-match over the B-cell complement-dependent lymphocytotoxicity cross-match.
    Gombos P; Opelz G; Scherer S; Morath C; Zeier M; Schemmer P; Langer RM; Süsal C
    Transplant Proc; 2013 May; 45(4):1383-5. PubMed ID: 23726578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of donor cell type on complement-dependent cytotoxicity crossmatch outcome for patients immunized against HLA class-II antigens.
    Arnold ML; Ensminger SM; Doxiadis II; Spriewald BM
    Exp Clin Transplant; 2008 Mar; 6(1):1-6. PubMed ID: 18405238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural HLA antibodies.
    Tongio MM; Falkenrodt A; Mitsuishi Y; Urlacher A; Bergerat JP; North ML; Mayer S
    Tissue Antigens; 1985 Nov; 26(5):271-85. PubMed ID: 3879021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General insufficiency of the classical CDC-based crossmatch to detect donor-specific anti-HLA antibodies leading to invalid results under recipients' medical treatment or underlying diseases.
    Schlaf G; Mauz-Körholz C; Ott U; Leike S; Altermann W
    Histol Histopathol; 2012 Jan; 27(1):31-8. PubMed ID: 22127594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological identification of five HLA-D associated (Ia-like) determinants.
    Albrechtsen D; Solheim BG; Thorsby E
    Tissue Antigens; 1977 Mar; 9(3):153-62. PubMed ID: 67654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HLA-A, B, C and DR antibodies in renal transplant recipients.
    Akiyama N; Kusaba R; Osawa N; Inou T; Kawamura A
    Jpn J Exp Med; 1980 Jun; 50(3):205-11. PubMed ID: 7001096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.